Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 17/11/2017
SIETES contiene 92128 citas

 
 
 1 a 20 de 42 siguiente >>
Presentar resultados
Seleccionar todas
1.Tiene citas relacionadas
Rochon PA, Vozoris N, Gill SS. The harms of benzodiazepines for patients with dementia . Can Med Assoc J 2017;189:E517-518. [Ref.ID 101525]
2.Enlace a cita originalTiene citas relacionadas Cita con resumen
Taipale H, Tolppanen A-M, Koponen M, Tanskanen A, Lavikainen P, Sund R, Tiihonen J, Hartikainen S. Risk of pneumonia associated with incident benzodiazepine use among community- dwelling adults with Alzheimer disease. Can Med Assoc J 2017;189:E519-529. [Ref.ID 101524]
3.Enlace a cita originalTiene citas relacionadas
Qaseem A, Kansagara D, Forciea MA, Cooke M, Denberg TD, for the Clinical Guidelines Committee of the American College of Physicians. Management of chronic insomnia disorder in adults: a clinical practice guideline from the American College of Physicians. Ann Intern Med 2016;165:125-33. [Ref.ID 100634]
4.Tiene citas relacionadas Cita con resumen
Wilt TJ, MacDonald R, Brasure M, Olson CM, Carlyle M, Fuchs E, Khawaja IS, Diem S, Koffel E, Ouellette J, Butler M, Kane RL. Pharmacologic treatment of insomnia disorder: an evidence report for a clinical practice guideline by the American College of Physicians. Ann Intern Med 2016;165:103-12. [Ref.ID 100633]
5.Enlace a cita original Cita con resumen
Kaufmann CN, Spira AP, Alexander GC, Rutkow L, Mojtabai R. Trends in prescribing of sedative-hypnotic medications in the USA: 1993–2010. Pharmacoepidemiol Drug Saf 2016;25:637-45. [Ref.ID 100393]
6.Enlace a cita original Cita con resumen
de Souto Barredo P, Lapeyre-Mestre M, Cefac P, Vellas B, Rolland Y. Effects of a geriatic intervention aiming to improve quality care in nursing home on benzodiazepine use and discontinuation. Br J Clin Pharmacol 2016;81:759-67. [Ref.ID 100180]
7. Cita con resumen
Anónimo. Drugs for insomnia. Med Lett Drugs Ther 2015;57:95-8. [Ref.ID 99452]
8.Enlace a cita original
Anónimo. Prescriptions for anxiolytics and hypnotics and risk of death. Eyes on Evidence 2014:junio. [Ref.ID 97691]
9. Cita con resumen
Berry SD, Lee Y, Cai S, Dore DD. Nonbenzodiazepine sleep medication use and hip fractures in nursing home residents. JAMA Intern Med 2013;173:754-61. [Ref.ID 95423]
11.Tiene citas relacionadas Cita con resumen
Widera E. What's to blame for falls and fractures? Poor sleep or the sleeping medication?. JAMA Intern Med 2013;173:761-2. [Ref.ID 94772]
12.Tiene citas relacionadas Cita con resumen
Berry SD, Lee Y, Cai S, Dore DD. Nonbenzodiazepine sleep medication use and hip fractures in nursing home residents. JAMA Intern Med 2013;173:754-61. [Ref.ID 94771]
13. Cita con resumen
Huedo-Medina TB, Kirsch I, Middlemass J, Klonizakis M, Sirwardena AN. Effectiveness of non-benzodiazepine hypnotics in treatment of adult insomnia: meta-analysis of data submitted to the Food and Drug Administration. BMJ 2013;346:10. [Ref.ID 94724]
14. Cita con resumen
Morin CM, Benca R. Chronic insomnia. Lancet 2012;379:1129-41. [Ref.ID 92548]
15. Cita con resumen
Kripke DF, Langer RD, Kline LE. Hypnotics' association with mortality or cancer: a matched cohort study. BMJ Open 2012:28 de febrero. [Ref.ID 92169]
16. Cita con resumen
Anónimo. Hypnotics. MeReC Bulletin 2012;22:8-10. [Ref.ID 92154]
17.
Zammit G. Comparative tolerability of newer agents for insomnia. Drug Saf 2009;32:735-48. [Ref.ID 86587]
18.Tiene citas relacionadas
Anónimo. Mélatonine: autorisée, mais toujours pas de preuve d'efficacité. Prescrire 2008;28:409. [Ref.ID 83087]
19.Tiene citas relacionadas
Anónimo. Rameltéon. Insomnie: non aux placebos à risque. Prescrire 2008;28:406-9. [Ref.ID 83086]
20.
Gull DG, Langford NJ. Drugs and driving. Adv Drug React Bull 2006;238:911-4. [Ref.ID 77996]
Seleccionar todas
 
 1 a 20 de 42 siguiente >>